Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Activation of matrix metalloproteinase-9 is associated with mobilization of bone marrow-derived cells after coronary stent implantation.

Inoue T, Taguchi I, Abe S, Toyoda S, Nakajima K, Sakuma M, Node K.

Int J Cardiol. 2011 Nov 3;152(3):332-6. doi: 10.1016/j.ijcard.2010.07.028. Epub 2010 Aug 30.

PMID:
20800911
2.

Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling.

Roh JD, Sawh-Martinez R, Brennan MP, Jay SM, Devine L, Rao DA, Yi T, Mirensky TL, Nalbandian A, Udelsman B, Hibino N, Shinoka T, Saltzman WM, Snyder E, Kyriakides TR, Pober JS, Breuer CK.

Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4669-74. doi: 10.1073/pnas.0911465107. Epub 2010 Mar 5.

3.

Late-term results of tissue-engineered vascular grafts in humans.

Hibino N, McGillicuddy E, Matsumura G, Ichihara Y, Naito Y, Breuer C, Shinoka T.

J Thorac Cardiovasc Surg. 2010 Feb;139(2):431-6, 436.e1-2. doi: 10.1016/j.jtcvs.2009.09.057.

4.

Determination of collagen content, concentration, and sub-types in kidney tissue.

Samuel CS.

Methods Mol Biol. 2009;466:223-35. doi: 10.1007/978-1-59745-352-3_16.

PMID:
19148607
5.

Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model.

Brennan MP, Dardik A, Hibino N, Roh JD, Nelson GN, Papademitris X, Shinoka T, Breuer CK.

Ann Surg. 2008 Sep;248(3):370-7. doi: 10.1097/SLA.0b013e318184dcbd.

6.

Matrix metalloproteinases in venous tissue remodeling and varicose vein formation.

Raffetto JD, Khalil RA.

Curr Vasc Pharmacol. 2008 Jul;6(3):158-72. Review.

PMID:
18673156
7.

Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: preliminary findings.

Nelson GN, Mirensky T, Brennan MP, Roh JD, Yi T, Wang Y, Breuer CK.

Arch Surg. 2008 May;143(5):488-94. doi: 10.1001/archsurg.143.5.488.

8.

Vascular adaptation and mechanical homeostasis at tissue, cellular, and sub-cellular levels.

Humphrey JD.

Cell Biochem Biophys. 2008;50(2):53-78. doi: 10.1007/s12013-007-9002-3. Epub 2007 Oct 24. Review.

PMID:
18209957
9.

Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model.

Roh JD, Nelson GN, Brennan MP, Mirensky TL, Yi T, Hazlett TF, Tellides G, Sinusas AJ, Pober JS, Saltzman WM, Kyriakides TR, Breuer CK.

Biomaterials. 2008 Apr;29(10):1454-63. doi: 10.1016/j.biomaterials.2007.11.041. Epub 2007 Dec 27.

10.

Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials.

Jones JA, McNally AK, Chang DT, Qin LA, Meyerson H, Colton E, Kwon IL, Matsuda T, Anderson JM.

J Biomed Mater Res A. 2008 Jan;84(1):158-66.

PMID:
17607751
11.

Evaluation of tissue-engineered vascular autografts.

Matsumura G, Ishihara Y, Miyagawa-Tomita S, Ikada Y, Matsuda S, Kurosawa H, Shin'oka T.

Tissue Eng. 2006 Nov;12(11):3075-83.

PMID:
17518623
12.

Production of extracellular matrix components in tissue-engineered blood vessels.

Heydarkhan-Hagvall S, Esguerra M, Helenius G, Söderberg R, Johansson BR, Risberg B.

Tissue Eng. 2006 Apr;12(4):831-42.

PMID:
16674296
13.

Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.

Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa H.

J Thorac Cardiovasc Surg. 2005 Jun;129(6):1330-8.

14.

MMP-9 regulates both positively and negatively collagen gel contraction: a nonproteolytic function of MMP-9.

Defawe OD, Kenagy RD, Choi C, Wan SY, Deroanne C, Nusgens B, Sakalihasan N, Colige A, Clowes AW.

Cardiovasc Res. 2005 May 1;66(2):402-9. Epub 2004 Dec 15.

15.

First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo.

Matsumura G, Miyagawa-Tomita S, Shin'oka T, Ikada Y, Kurosawa H.

Circulation. 2003 Oct 7;108(14):1729-34. Epub 2003 Sep 8.

16.

Transplantation of a tissue-engineered pulmonary artery.

Shin'oka T, Imai Y, Ikada Y.

N Engl J Med. 2001 Feb 15;344(7):532-3. No abstract available.

17.
18.

Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms.

Davis V, Persidskaia R, Baca-Regen L, Itoh Y, Nagase H, Persidsky Y, Ghorpade A, Baxter BT.

Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1625-33.

19.

Vascular myofibroblasts. Lessons from coronary repair and remodeling.

Zalewski A, Shi Y.

Arterioscler Thromb Vasc Biol. 1997 Mar;17(3):417-22. Review.

20.

Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.

Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV.

J Cell Biol. 1997 Feb 10;136(3):729-43.

Supplemental Content

Support Center